BG63708B1 - Лекарствени форми на трамадол - Google Patents

Лекарствени форми на трамадол Download PDF

Info

Publication number
BG63708B1
BG63708B1 BG103158A BG10315899A BG63708B1 BG 63708 B1 BG63708 B1 BG 63708B1 BG 103158 A BG103158 A BG 103158A BG 10315899 A BG10315899 A BG 10315899A BG 63708 B1 BG63708 B1 BG 63708B1
Authority
BG
Bulgaria
Prior art keywords
active ingredient
dosage forms
weight
pharmaceutical dosage
forms according
Prior art date
Application number
BG103158A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103158A (en
Inventor
Helmut Momberger
Marc Raber
Dieter Kuhn
Wolfgang Schmid
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of BG103158A publication Critical patent/BG103158A/xx
Publication of BG63708B1 publication Critical patent/BG63708B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
BG103158A 1996-07-25 1999-02-09 Лекарствени форми на трамадол BG63708B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19630035A DE19630035A1 (de) 1996-07-25 1996-07-25 Tramadol Multiple Unit Formulierungen
PCT/EP1997/003934 WO1998004249A2 (de) 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen

Publications (2)

Publication Number Publication Date
BG103158A BG103158A (en) 1999-08-31
BG63708B1 true BG63708B1 (bg) 2002-10-31

Family

ID=7800815

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103158A BG63708B1 (bg) 1996-07-25 1999-02-09 Лекарствени форми на трамадол

Country Status (29)

Country Link
US (2) US5955104A (ru)
EP (1) EP0917463B1 (ru)
JP (1) JP3631762B2 (ru)
KR (1) KR100474793B1 (ru)
CN (1) CN1111402C (ru)
AR (1) AR008002A1 (ru)
AT (1) ATE213408T1 (ru)
AU (1) AU737121B2 (ru)
BG (1) BG63708B1 (ru)
BR (1) BR9710761A (ru)
CA (1) CA2211284C (ru)
CZ (1) CZ296964B6 (ru)
DE (2) DE19630035A1 (ru)
DK (1) DK0917463T3 (ru)
EE (1) EE03742B1 (ru)
ES (1) ES2171268T3 (ru)
HK (1) HK1020876A1 (ru)
HU (1) HU227971B1 (ru)
IL (1) IL127915A (ru)
NO (1) NO324207B1 (ru)
NZ (1) NZ333822A (ru)
PL (1) PL188834B1 (ru)
PT (1) PT917463E (ru)
RU (1) RU2201223C2 (ru)
SK (1) SK285300B6 (ru)
TW (1) TW495363B (ru)
UA (1) UA52679C2 (ru)
WO (1) WO1998004249A2 (ru)
ZA (1) ZA975408B (ru)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
US6197347B1 (en) * 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
DE19901687B4 (de) * 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
DE19901686A1 (de) 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
CN1202815C (zh) * 1999-08-31 2005-05-25 格吕伦塔尔有限公司 含有曲马朵糖精盐的持续释放给药剂型
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA02004293A (es) 1999-10-29 2002-10-31 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada..
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6620431B1 (en) 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
WO2001096260A1 (fr) * 2000-06-14 2001-12-20 Chisso Corporation Procede de production de granules bioactifs enrobes
CA2415080A1 (en) * 2000-07-06 2002-01-17 Delsys Pharmaceutical Corporation Improved thyroid hormone formulations
EP1337244A4 (en) 2000-10-30 2006-01-11 Euro Celtique Sa HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
AU2002355266A1 (en) * 2001-07-23 2003-02-17 Brigham And Women's Hospital, Inc. Analgesic methods using endothelin receptor ligands
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
SI1476138T1 (sl) * 2002-02-21 2012-07-31 Valeant Internat Barbados Srl Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
ATE491439T1 (de) * 2002-08-15 2011-01-15 Euro Celtique Sa Pharmazeutische zusammensetzungen enthaltend einen opioidantagonisten
EP1424068B1 (de) * 2002-11-27 2006-08-02 ORAMON-Arzneimittel GmbH & Co. KG Verfahren zur Herstellung von Pellets, enthaltend ein tri- oder tetracyclisches Antidepressivum sowie diese Pellets enthaltende pharmazeutische Zubereitungen
KR100712356B1 (ko) * 2003-01-23 2007-05-02 (주)아모레퍼시픽 서방성 제제 및 그의 제조방법
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
US20050053669A1 (en) * 2003-09-05 2005-03-10 Boehringer Ingelheim International Gmbh Administration form for the oral application of poorly soluble acidic and amphorteric drugs
WO2005034859A2 (en) * 2003-10-03 2005-04-21 Elite Laboratories Inc. Extended release formulations of opioids and method of use thereof
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
CN1988889A (zh) * 2004-07-22 2007-06-27 株式会社太平洋 含托吡酯的缓释制剂及其制备方法
MX2007002135A (es) 2004-09-01 2007-04-02 Euro Celtique Sa Formas farmaceuticas de opioide que tienen una cprom y un auc en el estado estacionario proporcional a la dosis y una cmax de la dosis unica menor que la proporcional a la dosis.
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
DK1915137T3 (da) * 2005-08-10 2013-11-04 Add Advanced Drug Delivery Technologies Ltd Oralt præparat med kontrolleret frisætning
MX2008006037A (es) * 2005-11-10 2009-03-03 Circ Pharma Res And Dev Ltd Drogas para el sistema nervioso central para administracion una-vez-al-dia.
US20070185145A1 (en) * 2006-02-03 2007-08-09 Royds Robert B Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
US20070264335A1 (en) * 2006-05-09 2007-11-15 Sherman Bernard C Modified release tablets comprising tramadol
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
ATE476176T1 (de) * 2007-03-02 2010-08-15 Farnam Co Inc Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
CA2696341C (en) 2007-08-13 2016-05-17 Abuse Deterrent Pharmaceutical Llc Abuse resistant drugs, method of use and method of making
CN101095666B (zh) * 2007-08-14 2010-10-06 石药集团欧意药业有限公司 一种盐酸曲马多缓释片剂及其制备方法
CZ300468B6 (cs) * 2007-09-20 2009-05-27 Zentiva, A. S Léková forma obsahující tramadol s kontrolovaným uvolnováním po dobu 24 hodin a zpusob její prípravy
WO2009087690A2 (en) * 2008-01-11 2009-07-16 Jubilant Organosys Limited Multiparticulate extended release pharmaceutical composition of carbamazepine and process for manufacturing the same
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
CN102202654B (zh) * 2008-09-04 2014-07-30 法纳姆公司 可咀嚼的缓释制剂
FR2938431B1 (fr) * 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
HUE032275T2 (en) 2008-11-18 2017-09-28 Ucb Biopharma Sprl Sustained release formulations containing a 2-oxo-pyrrolidine derivative
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
AU2011276170B2 (en) 2010-07-06 2016-03-10 Grunenthal Gmbh Novel gastro- retentive dosage forms comprising a GABA Analog and an opioid
PL2872121T3 (pl) 2012-07-12 2019-02-28 SpecGx LLC Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
US20140275038A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
DE4428444A1 (de) * 1994-08-11 1996-02-15 Dresden Arzneimittel Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen

Also Published As

Publication number Publication date
PL331387A1 (en) 1999-07-05
DK0917463T3 (da) 2002-06-10
IL127915A0 (en) 1999-11-30
CZ296964B6 (cs) 2006-08-16
JP2000515871A (ja) 2000-11-28
JP3631762B2 (ja) 2005-03-23
KR100474793B1 (ko) 2005-03-08
RU2201223C2 (ru) 2003-03-27
SK285300B6 (sk) 2006-10-05
HUP9903053A2 (hu) 2000-01-28
EP0917463B1 (de) 2002-02-20
HK1020876A1 (en) 2000-05-26
NO324207B1 (no) 2007-09-10
CN1226824A (zh) 1999-08-25
EE03742B1 (et) 2002-06-17
PL188834B1 (pl) 2005-04-29
DE19630035A1 (de) 1998-01-29
US6436438B1 (en) 2002-08-20
HUP9903053A3 (en) 2000-02-28
EP0917463A2 (de) 1999-05-26
ES2171268T3 (es) 2002-09-01
NO990261D0 (no) 1999-01-21
WO1998004249A2 (de) 1998-02-05
AR008002A1 (es) 1999-11-24
BG103158A (en) 1999-08-31
CA2211284C (en) 2001-10-23
NO990261L (no) 1999-01-21
WO1998004249A3 (de) 1998-04-30
IL127915A (en) 2001-08-08
UA52679C2 (ru) 2003-01-15
HU227971B1 (en) 2012-07-30
SK9899A3 (en) 1999-09-10
KR20000029530A (ko) 2000-05-25
NZ333822A (en) 1999-11-29
TW495363B (en) 2002-07-21
AU3849197A (en) 1998-02-20
EE9900031A (et) 1999-08-16
PT917463E (pt) 2002-07-31
US5955104A (en) 1999-09-21
ZA975408B (en) 1998-01-05
ATE213408T1 (de) 2002-03-15
CA2211284A1 (en) 1998-01-25
CZ18599A3 (cs) 1999-04-14
BR9710761A (pt) 1999-08-17
DE59706441D1 (de) 2002-03-28
CN1111402C (zh) 2003-06-18
AU737121B2 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
BG63708B1 (bg) Лекарствени форми на трамадол
FI78835B (fi) Foerfarande foer framstaellning av en ny dipyridamol-retardform.
US5529790A (en) Delayed, sustained-release diltiazem pharmaceutical preparation
RU2072840C1 (ru) Твердая лекарственная форма пролонгированного действия для лечения сердечно-сосудистых заболеваний
US7897173B2 (en) Sustained-release, oral pharmaceutical formulations and methods of making and using same
CA2348090C (en) Oral pulsed dose drug delivery system
JP2916978B2 (ja) 放出開始制御型製剤
US5296232A (en) Pharmaceutical formulation which does not induce tolerance
US20030035835A1 (en) Sustained-release form of administration containing tramadol saccharinate
NO333986B1 (no) Farmasøytiske salter av aktive forbindelser, et medikament inneholdende dem, samt anvendelse av saltene
DK151608B (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
JP2004521910A (ja) トラマドール系薬剤
MX2011006012A (es) Granulos de tamsulosina para combinacion de dosis fija.
KR20190064215A (ko) 토파시티닙을 포함하는 약제학적 조성물
JPH0451528B2 (ru)
US8173164B2 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
MXPA99000903A (en) Tramadol multiple unit formulations